{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:13:57Z","timestamp":1760328837470,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004476","name":"Chinese Center for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.04.070","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T23:09:55Z","timestamp":1588201795000},"page":"5071-5075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650"],"prefix":"10.1016","volume":"38","author":[{"given":"Qiu-dong","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-ning","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-jiao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-cheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-li","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.070_b0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmv.25688","article-title":"The 2019-new coronavirus epidemic: evidence for virus evolution","volume":"92","author":"Benvenuto","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2020.04.070_b0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel Coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.04.070_b0015","unstructured":"WHO. Coronavirus disease 2019 (COVID-19) Situation Report - 57, https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200317-sitrep-57-covid-19.pdf?sfvrsn=a26922f2_4; 17 March 2020."},{"key":"10.1016\/j.vaccine.2020.04.070_b0020","first-page":"nwaa036","article-title":"On the origin and continuing evolution of SARS-CoV-2","author":"Tang","year":"2020","journal-title":"Nat Sci Rev"},{"key":"10.1016\/j.vaccine.2020.04.070_b0025","doi-asserted-by":"crossref","unstructured":"Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor. J BioRxiv. 2020:2020.02.19.956235. http:\/\/doi.org\/10.1101\/2020.02.19.956235 %J bioRxiv.","DOI":"10.1101\/2020.02.19.956235"},{"key":"10.1016\/j.vaccine.2020.04.070_b0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"The Lancet"},{"issue":"6483","key":"10.1016\/j.vaccine.2020.04.070_b0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.04.070_b0040","doi-asserted-by":"crossref","unstructured":"Fast E, Chen B. Potential T-cell and B-cell Epitopes of 2019-nCoV. bioRxiv. 2020:2020.02.19.955484. http:\/\/doi.org\/10.1101\/2020.02.19.955484 %J bioRxiv.","DOI":"10.1101\/2020.02.19.955484"},{"key":"10.1016\/j.vaccine.2020.04.070_b0045","first-page":"11","article-title":"Vaccines and global health: In search of a sustainable model for vaccine development and delivery","author":"Rappuoli","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2020.04.070_b0050","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.070_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002829","article-title":"Reliable B cell epitope predictions: impacts of method development and improved benchmarking","volume":"8","author":"Kringelum","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2020.04.070_b0060","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2020.04.070_b0065","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan- 4.0: Improved peptide-MHC Class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.070_b0070","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41587-019-0280-2","article-title":"Predicting HLA class II antigen presentation through integrated deep learning","volume":"37","author":"Chen","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2020.04.070_b0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","article-title":"Toward the estimation of the absolute quality of individual protein structure models","volume":"27","author":"Benkert","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2020.04.070_b0080","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.070_b0085","first-page":"267","article-title":"Cloning and expression of SARS coronavirus spike gene fragment and its application","volume":"19","author":"Yi","year":"2003","journal-title":"Chin J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.070_b0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.04.070_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","author":"Andersen","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.04.070_b0100","doi-asserted-by":"crossref","unstructured":"Ju B, Zhang Q, Ge X, Wang R, Yu J, Shan S, et al. Potent human neutralizing antibodies elicited by SARS-CoV-2 infection. 2020:2020.03.21.990770. http:\/\/doi.org\/10.1101\/2020.03.21.990770 %J bioRxiv.","DOI":"10.1101\/2020.03.21.990770"},{"key":"10.1016\/j.vaccine.2020.04.070_b0105","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.04.070_b0110","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.2174\/138161210793292447","article-title":"Epitope discovery and their use in peptide based vaccines","volume":"16","author":"Dudek","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.vaccine.2020.04.070_b0115","doi-asserted-by":"crossref","unstructured":"Feng Y, Qiu M, Zou S, Li Y, Luo K, Chen R, et al. Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus in China (SARS-CoV-2). 2020:2020.03.03.962332. http:\/\/doi.org\/10.1101\/2020.03.03.962332 %J bioRxiv.","DOI":"10.1101\/2020.03.03.962332"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:54Z","timestamp":1759401834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20305879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":23,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20305879"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}